Daniel Shaker - Green Thumb VP Sales
| GTBIF Stock | USD 9.28 0.32 3.33% |
Insider
Daniel Shaker is VP Sales of Green Thumb Industries
| Age | 52 |
| Phone | 312 471 6720 |
| Web | https://www.gtigrows.com |
Green Thumb Management Efficiency
The company has return on total asset (ROA) of 0.0615 % which means that it generated a profit of $0.0615 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0562 %, meaning that it generated $0.0562 on every $100 dollars invested by stockholders. Green Thumb's management efficiency ratios could be used to measure how well Green Thumb manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| John Weston | cbdMD Inc | N/A | |
| Thomas Flow | Akanda Corp | 46 | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Rami Levy | INC Research Holdings | 59 | |
| BCom BAcc | Akanda Corp | 44 | |
| Sandra Beaver | Evolus Inc | 46 | |
| Jeff Holm | Biofrontera | N/A | |
| Mark Baldyga | Biofrontera | N/A | |
| Sibyl Swift | cbdMD Inc | 43 | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| BComm BCom | Akanda Corp | 68 | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Hermann Lubbert | Biofrontera | 68 | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Erica CPA | Biofrontera | 39 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Amos Cohen | INC Research Holdings | 45 | |
| Tejinder Virk | Akanda Corp | 42 | |
| David Erickson | Evolus Inc | N/A | |
Management Performance
| Return On Equity | 0.0562 | |||
| Return On Asset | 0.0615 |
Green Thumb Industries Leadership Team
Elected by the shareholders, the Green Thumb's board of directors comprises two types of representatives: Green Thumb inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Green. The board's role is to monitor Green Thumb's management team and ensure that shareholders' interests are well served. Green Thumb's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Green Thumb's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anthony Georgiadis, CFO, Director | ||
| Mathew Faulkner, Chief Officer | ||
| Linda Marsicano, VP Communications | ||
| Benjamin Kovler, Chairman Founder | ||
| Dina Rollman, Sr Affairs | ||
| Swadheen Sehgal, Chief Officer | ||
| Daniel Shaker, VP Sales | ||
| Bret Kravitz, Chief Counsel | ||
| Andrew Grossman, Head of Capital Markets | ||
| Kate Denton, Senior Vice President of Marketing |
Green Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Green Thumb a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0562 | |||
| Return On Asset | 0.0615 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 2.64 B | |||
| Shares Outstanding | 207.34 M | |||
| Shares Owned By Insiders | 3.37 % | |||
| Shares Owned By Institutions | 9.06 % | |||
| Price To Earning | 189.29 X | |||
| Price To Book | 1.34 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Green OTC Stock
Green Thumb financial ratios help investors to determine whether Green OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Green with respect to the benefits of owning Green Thumb security.